Repurposing High-Throughput Imaging Tests for Drug Discovery Allows for Biological Activity Prediction

Document Type : Primary Research paper


1 Sr. Manager, Capgemini America, 79 5th Avenue, Suite 300, New York, NY 10003, USA

2 Director of Sales, Career Soft Solutions Inc, 145 Talmadge rd Edison NJ 08817, Middlesex, USA


A glucocorticoid receptor High-Throughout (cell) Imaging (HTI) screen to predict target protein activity in a variety of seemingly unrelated tests. The repurposing method raised hit rates by 60 to 250 times over the primary project assays in two ongoing drug discovery projects, while also boosting the chemical structure diversity of the hits using machine learning. Our findings show that data from existing HTI screens is a significant source of data that may be repurposed to aid drug discovery efforts.


Volume 12, Issue 3 - Serial Number 3
ICMMNT-2021 International Virtual Conference on Materials, Manufacturing and Nanotechnology, 30th June, 2021.
June 2021
Pages 2431-2443